Kontafarma China Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-454.00
-97.00
-43.00
-117.00
-54.00
0.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
-19.00
14.00
-112.00
-53.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
66.00
34.00
22.00
-24.00
45.00
0.00
Cash Flow from Investing Activities
8.00
-7.00
142.00
111.00
26.00
0.00
Cash Flow from Financing Activities
-79.00
-29.00
-182.00
-111.00
-67.00
0.00
Net Cash Inflow / Outflow
-14.00
2.00
-44.00
-51.00
8.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-9.00
4.00
-27.00
-27.00
3.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kontafarma China Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-454.730000000149
-55.063000000018
-399.00
-725.84%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.55900000000051
-3.90000000000128
4.00
139.97%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
66.3730000000217
-34.5950000000114
100.00
291.86%
Cash Flow from Investing Activities
8.36500000000274
-38.8460000000127
46.00
121.53%
Cash Flow from Financing Activities
-79.403000000026
-29.6360000000097
-50.00
-167.93%
Net Cash Inflow / Outflow
-14.5210000000048
-94.2070000000309
80.00
84.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-9.85600000000323
8.87000000000291
-17.00
-211.12%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 89.88% vs 53.59% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
66.37
34.96
89.88%






